Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?

To: Jorj X Mckie who wrote (8984)	10/23/2002 4:42:12 PM
From: Jorj X Mckie	Respond to of 57110

16:40 ET RNDC Raindance beats by 3 cents, raises EBITDA guidance (3.17 +0.16) Reports Q3 (Sep) earnings of $0.01 per share, $0.03 better than the Multex consensus of ($0.02); revenues rose 55.4% year/year to $15.7 mln vs the $15.3 mln consensus. Reiterates 2002 guidance of $60-$62 mln in rev and raises EBITDA guidance to $8.5-$9.0 mln from $6.5 mln. 16:38 ET DRIV Digital River misses by a penny (9.95 -0.06) Reports Q3 net of $0.05 a share, $0.01 worse than the Multex consensus. Rev rose 35% to $18.9 mln (consensus $18.58 mln). For Q4, co sees EPS of $0.14 on revs of $20 mln (consensus $0.13/$20.98 mln). In 2003, sees EPS of $0.50-$0.52 on revs of $91-$93 mln (consensus $0.52/$93.57 mln). 16:37 ET BVSN BroadVision beats by 21 cents (1.56 +0.06) Reports Q3 (Sep) loss of $0.07 per share, $0.21 better than the Multex consensus of ($0.28); revs were $27.2 mln, vs consensus of $27.5 mln. 16:36 ET MCHP Microchip matches estimates (25.65 +1.26) Reports Q2 (Sep) earnings of $0.17 per share, in line with the Multex consensus of $0.17; revs were $169.7 mln, vs consensus of $170.5 mln; revenue for the third fiscal quarter ending Dec. 31, 2002 is currently anticipated to be approximately $173 to $178 million -- Multex consensus estimate is for revs of $177.7 mln. 16:34 ET MANH Manhattan Assoc matches EPS consensus on light revs (17.98 +0.08) Reports Q3 earnings of $0.21 per share (ex-items, in line with the Multex consensus. Revs rose 8% to $42.86 mln (consensus $45.25 mln). For Q4, co sees EPS of $0.20-$0.26 (consensus $0.24). 16:32 ET CRUS Cirrus Logic matches estimates (2.20 +0.20) Reports Q2 (Sep) loss of $0.09 per share, in line with the Multex consensus of ($0.09); revenues fell 3.4% year/year to $73.3 mln vs the $72.5 mln consensus; Q3 loss per share is expected to be $0.12-$0.16 -- Multex consensus estimate is for loss of $0.08 per share. 16:30 ET CYTC CYTYC Corp beats by 2 cents (10.38 -0.41) Reports Q3 (Sep) earnings of $0.12 per share, $0.02 better than the Multex consensus of $0.10; revs were $58.5 mln, vs consensus of $57.0 mln. 16:29 ET POWI Power Integrations matches estimates (13.25 -0.18) Reports Q3 (Sep) earnings of $0.08 per share, in line with the Multex consensus of $0.08; revenues rose 22.5% year/year to $28.2 mln vs the $28.2 mln consensus; says Q4 earnings in the fourth quarter should be in the range of $0.08 to $0.09 per share -- Multex consensus estimate is for earnings of $0.09 per share. 16:26 ET ESST ESS Tech misses by 9 cents (6.00 +0.50) Reports Q3 (Sep) earnings of $0.07 per share, $0.09 worse than the Multex consensus of $0.16; revs were $60.7 mln, vs consensus of $62.1 mln. Expects Q4 EPS of $0.02-$0.05 on revs of $45-$50 mln, vs consensus of $0.07 and $54.4 mln. 16:26 ET WLP WellPoint Health tops estimates (84.56 -1.07) Reports Q3 (Sep) earnings of $1.17 per share, $0.04 better than the Multex consensus of $1.13; revs were $4.52 bln, vs consensus of $4.39 bln. 16:25 ET AMGN Amgen beats by $0.02; gives Enbrel guidance (50.00 +0.20) Reports Q3 earnings of $0.34 per share, $0.02 better than the Multex consensus. Revs rose 44.5% year/year to $1.45 bln vs the $1.44 bln consensus. AMGN expects Enbrel sales to be at, or slightly below the low end of the range. Informed by the FDA that it expects to inspect the new Enbrel facility in Nov.